Geode Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
|
|||||
|
2025
Q1 | $6.37M | Sell |
|
|||||
|
2024
Q4 | $8.27M | Buy |
|
|||||
|
2024
Q3 | $15.6M | Buy |
|
|||||
|
2024
Q2 | $8.3M | Buy |
|
|||||
|
2024
Q1 | $7.98M | Buy |
|
|||||
|
2023
Q4 | $6.71M | Buy |
|
|||||
|
2023
Q3 | $7.08M | Buy |
|
|||||
|
2023
Q2 | $7.02M | Buy |
|
|||||
|
2023
Q1 | $3.2M | Buy |
|
|||||
|
2022
Q4 | $4.88M | Buy |
|
|||||
|
2022
Q3 | $4.46M | Buy |
|
|||||
|
2022
Q2 | $2.93M | Buy |
|
|||||
|
2022
Q1 | $4.27M | Buy |
|
|||||
|
2021
Q4 | $5.77M | Buy |
|
|||||
|
2021
Q3 | $9.11M | Buy |
|
|||||
|
2021
Q2 | $9.52M | Buy |
|
|||||
|
2021
Q1 | $7.87M | Buy |
|
|||||
|
2020
Q4 | $5.89M | Sell |
|
|||||
|
2020
Q3 | $6.66M | Buy |
|
|||||
|
2020
Q2 | $5.87M | Buy |
|
|||||
|
2020
Q1 | $4.16M | Buy |
|
|||||
|
2019
Q4 | $4.78M | Buy |
|